Skip to main navigation Skip to search Skip to main content

Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer

  • A. W. Menzin
  • , S. A. King
  • , J. K. Aikins
  • , J. J. Mikuta
  • , S. C. Rubin
  • University of Pennsylvania

Research output: Contribution to journalLetterpeer-review

26 Scopus citations
Original languageEnglish
Pages (from-to)103
Number of pages1
JournalGynecologic Oncology
Volume54
Issue number1
StatePublished - 1994

Keywords

  • Adenocarcinoma/drug therapy
  • Aged
  • Female
  • Humans
  • Paclitaxel/therapeutic use
  • Salvage Therapy
  • Skin Neoplasms/drug therapy
  • Uterine Cervical Neoplasms/drug therapy

Fingerprint

Dive into the research topics of 'Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer'. Together they form a unique fingerprint.

Cite this